Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
LSI Industries | LYTS | Nov 15, 2024 | 20.07 | -1.86 |
Ltc Properties | LTC | Nov 15, 2024 | 38.20 | +0.10 |
Lucas GC | LGCL | Nov 15, 2024 | 1.05 | -11.02 |
Lucid Diagnostics | LUCD | Nov 15, 2024 | 0.99 | -2.30 |
Lucid Group | LCID | Nov 15, 2024 | 2.01 | -3.37 |
Lufax ADR | LU | Nov 15, 2024 | 2.31 | -0.86 |
Lululemon Athletica | LULU | Nov 15, 2024 | 320.01 | -3.10 |
Lulus Fashion Lounge | LVLU | Nov 15, 2024 | 1.43 | +1.06 |
Lumen Technologies | LUMN | Nov 15, 2024 | 8.54 | -1.04 |
Lument Finance Trust | LFT | Nov 15, 2024 | 2.52 | +2.44 |
Lument Finance Trust A Pref | LFT-A | Nov 15, 2024 | 22.74 | -1.77 |
Lumentum | LITE | Nov 15, 2024 | 81.45 | -4.32 |
Luminar Technologies A | LAZR | Nov 15, 2024 | 0.98 | -4.85 |
Lumos Pharma | LUMO | Nov 15, 2024 | 4.33 | 0.00 |
Luna Innovations | LUNA | Nov 15, 2024 | 1.63 | +3.82 |
Luokung Technology | LKCO | Nov 15, 2024 | 1.68 | +1.02 |
Luxfer | LXFR | Nov 15, 2024 | 14.34 | -2.12 |
LuxUrban Hotels | LUXH | Nov 15, 2024 | 0.04 | -6.59 |
Luxurban Hotels Pref | LUXHP | Nov 15, 2024 | 15.60 | -2.50 |
Lxp Industrial Trust | LXP | Nov 15, 2024 | 9.18 | -0.86 |
LXP Industrial Trust C Pref | LXP-C | Nov 15, 2024 | 50.56 | +0.70 |
Lyell Immunopharma | LYEL | Nov 15, 2024 | 1.10 | 0.00 |
Lyft A | LYFT | Nov 15, 2024 | 18.12 | +1.12 |
LyondellBasell Industries Nv A | LYB | Nov 15, 2024 | 82.65 | +0.11 |
Lyra Therapeutics | LYRA | Nov 15, 2024 | 0.17 | -5.56 |
Lytus Technologies | LYT | Nov 15, 2024 | 1.69 | -5.06 |
M&T Bank | MTB | Nov 15, 2024 | 214.74 | +0.69 |
M&T Bank ADR Prej J | MTB-J | Nov 15, 2024 | 27.39 | -0.33 |
M&T Bank H Pref | MTB-H | Nov 15, 2024 | 25.25 | -0.59 |
M-tron Industries | MPTI | Nov 15, 2024 | 56.40 | -5.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.